Somewhat Favorable Media Coverage Somewhat Unlikely to Impact Humana (HUM) Stock Price
Media stories about Humana (NYSE:HUM) have trended somewhat positive this week, according to Accern Sentiment. Accern identifies negative and positive media coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Humana earned a news impact score of 0.10 on Accern’s scale. Accern also assigned press coverage about the insurance provider an impact score of 45.5550157387877 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.
These are some of the media headlines that may have impacted Accern Sentiment’s rankings:
- Get to know the new CEO of the Humana Foundation (bizjournals.com)
- Humana Adds The Five Minute Journal Mobile App to Wellness Rewards Program, Stressing Importance of Mindfulness (markets.financialcontent.com)
- Humana Inc (HUM) Forecasted to Post Q2 2018 Earnings of $3.46 Per Share (americanbankingnews.com)
- Humana Foundation Announces Focus for the Future: Addressing Social Determinants of Health for Sustainable Community Impact (finance.yahoo.com)
- Humana Inc (HUM) Expected to Post Quarterly Sales of $13.02 Billion (americanbankingnews.com)
Humana (NYSE:HUM) traded up $5.58 on Wednesday, reaching $275.75. The company had a trading volume of 1,116,839 shares, compared to its average volume of 1,203,518. The company has a current ratio of 1.61, a quick ratio of 1.61 and a debt-to-equity ratio of 0.35. Humana has a fifty-two week low of $186.25 and a fifty-two week high of $276.07. The company has a market cap of $39,320.00, a price-to-earnings ratio of 21.71, a price-to-earnings-growth ratio of 1.68 and a beta of 0.88.
The business also recently declared a quarterly dividend, which will be paid on Friday, January 26th. Investors of record on Friday, December 29th will be given a dividend of $0.40 per share. The ex-dividend date of this dividend is Thursday, December 28th. This represents a $1.60 annualized dividend and a yield of 0.58%. Humana’s payout ratio is 12.60%.
Humana announced that its Board of Directors has authorized a share buyback program on Thursday, December 14th that allows the company to repurchase $3.00 billion in outstanding shares. This repurchase authorization allows the insurance provider to repurchase shares of its stock through open market purchases. Stock repurchase programs are generally an indication that the company’s board believes its shares are undervalued.
Several research firms have weighed in on HUM. Jefferies Group raised Humana from a “hold” rating to a “buy” rating and set a $221.00 price target on the stock in a report on Friday, January 12th. Zacks Investment Research raised Humana from a “hold” rating to a “buy” rating and set a $297.00 price objective on the stock in a report on Monday. JPMorgan Chase & Co. cut Humana from an “overweight” rating to a “neutral” rating and set a $253.00 price objective on the stock. in a report on Monday, October 9th. Goldman Sachs Group initiated coverage on Humana in a report on Wednesday, January 3rd. They set a “buy” rating and a $305.00 price objective on the stock. Finally, ValuEngine cut Humana from a “buy” rating to a “hold” rating in a report on Tuesday, October 10th. Nine investment analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. Humana has an average rating of “Buy” and a consensus price target of $260.10.
In other news, VP Timothy S. Huval sold 1,382 shares of Humana stock in a transaction that occurred on Tuesday, December 19th. The stock was sold at an average price of $246.04, for a total value of $340,027.28. Following the sale, the vice president now directly owns 11,557 shares in the company, valued at approximately $2,843,484.28. The sale was disclosed in a filing with the SEC, which is available through this link. Also, SVP Jody L. Bilney sold 7,054 shares of Humana stock in a transaction that occurred on Monday, December 18th. The stock was sold at an average price of $247.89, for a total value of $1,748,616.06. Following the completion of the sale, the senior vice president now owns 11,704 shares in the company, valued at $2,901,304.56. The disclosure for this sale can be found here. Over the last quarter, insiders sold 10,115 shares of company stock worth $2,501,627. Corporate insiders own 0.80% of the company’s stock.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.